Benefits to Authors

Articles published in npj Vaccines are open access, allowing for the widest dissemination, visibility, and impact of your research. New content is published online each week to provide timely communication to the community and keep publication times to a minimum.

Open access offers authors a number of benefits including: 

  • increased citation and usage
  • greater public engagement
  • faster impact
  • wider collaboration
  • compliance with funder mandates
  • increased interdisciplinary conversation

Creative Commons License

Articles are published under a CC BY license (Creative Commons Attribution 4.0 International License). The CC BY license is preferred by many research funding bodies, and allows for a maximum dissemination and re-use of open-access materials. Alternative Creative Commons licenses are available on request: please contact the editorial office on acceptance of your article to discuss these options.

Under Creative Commons, authors retain copyright of their work. Learn more about Creative Commons licenses and the licesne options available in npj Vaccines.

Publishing with the journal offers authors a number of benefits, including:


Part of the Nature Partner Journal series, the journal is published by Springer Nature in partnership with the Sealy Center for Vaccine Development (SCVD). All Nature Partner Journal titles have strong editorial values and adhere to a modified set of Nature editorial standards under the leadership of Nature Editor-in-Chief, Sir Philip Campbell.

Ease of submission
Manuscripts submitted to npj Vaccines do not need to adhere to our formatting requirements at the point of initial submisson; formatting requirements only apply at the time of acceptance.

Comprehensive and rigorous peer review
Manuscripts are evaluated by experienced editors and reviewers who are authorities in your field.

Rapid turnaround times
An average time to first decision within 26 days; the final version of a manuscript is published online within 25 days of acceptance.

Global reach and discoverability
Enhanced browsing and searching on means that articles are promoted, marketed and presented alongside other Nature Research content. Article level metrics showcase your personal research impact in academia and beyond.

Professionally written Editorial Summaries
Profesionally written Editorial Summaries accompany each original research article, opening up your research to the scientific community and succintly communicating why your article is important.

Articles published in npj Vaccines will be included in montly article e-alerts and regular email updates. A featured article is highlighted on the journal homepage each month, and may be selected to appear on the portal for partner publishing

Articles published in npj Vaccines may be promoted by press release to the general or scientific press, utilizing Nature Research's extensive media database.

Abstracting and indexing
npj Vaccines is listed within leading abstracting and indexing services including PubMed Central, PubMed, Science Citation Index Expanded (SCIE), Biological Abstracts, BIOSIS Previews and Directory of Open Access Journals (DOAJ).